Page 26 - Martin Marietta - 2021 Proxy Statement

DIRECTOR NOMINEES / PROPOSAL 1: ELECTION OF DIRECTORS

Ms. Perez is an investment consultant with DeRoy & Devereaux, an Key attributes,
independent investment adviser, where she has provided client experience and skills:
consulting services since 2015. She was previously Owner and
Managing Partner of The Medallion Company, LLC, a consulting firm, • Significant business, financial
from 2003 to 2015. Ms. Perez was previously a Director of GenOn and private investment
Energy, Inc. (NYSE: GEN), one of the largest power producers in the experience
United States, from 2002 to 2012, and served as the Chairman of • Significant expertise with respect
the audit committee of GenOn Energy, Inc. from 2002 to 2007 and a to financial statements,
member of its audit and risk and finance oversight committees from corporate finance, accounting
2008 to 2012. Previously, she was Vice President of Loomis, Sayles & and capital markets, mergers and
Company, L.P. and co-founder, President and Chief Executive Officer acquisitions, and strategic
LAREE E. of Medallion Investment Company, Inc. In addition to civic and analysis
charitable organizations, Ms. Perez served as Vice Chairman of the • Insight into auditing best
PEREZ Board of Regents at Baylor University and previously served on the
practices
Board of Trustees of New Mexico State University, where she was
Director Since: 2004 • Familiarity with the southwestern
also Chairman of the Board. Ms. Perez earned a Bachelor’s degree
Age: 67 United States
from Baylor University in Finance and Economics.
Committees:

Chair

Mr. Pike joined the Martin Marietta Board in July 2019. Mr. Pike served Key attributes,
as Chief Executive Officer and a member of the Board of Directors of experience and skills:
Quintiles Transnational Holdings, Inc. (Quintiles) from April 2012 until its
merger with IMS Health in December 2016 to create IQVIA (NYSE:IQV). • More than 15 years of C-Suite
Before its merger with IMS, Quintiles had a network of more than experience
35,000 employees conducting business in approximately 100 countries. • Broad strategic and financial
Mr. Pike led Quintiles through a successful public offering and helped experience
grow into a Fortune 500 company. Under Mr. Pike’s leadership, • Extensive experience in mergers
Quintiles was named one of the world’s Most Ethical Companies in and acquisitions, integration, and
2016. Prior to Quintiles, Mr. Pike spent 22 years at Accenture (NYSE: strategic development and
ACN), a leading global professional services company, providing a broad analysis
THOMAS H. range of services and solutions in strategy, consulting, digital,
• Significant mentorship, business
PIKE technology and operations, until December 2009. At Accenture, and operating experience in a
Mr. Pike’s roles included serving as Chief Risk Officer and Managing
Director Since: 2019 Director of the North America Health and Products business areas. He public company
Age: 61 previously served as the global Chief Operating Officer for Accenture’s • Valuable knowledge of financial
Committees: Resources operating group and had also served as Accenture’s Chief system management, public
Strategy Officer. Since leaving Accenture in December 2009 and until company accounting, disclosure
joining Quintiles in April 2012, Mr. Pike was involved with a number of requirements and financial
start-ups in the technology and healthcare sectors. Early in his career markets
Mr. Pike was a consultant with McKinsey & Company. Mr. Pike earned
his Bachelor’s degree in accounting from the University of Delaware.

Audit Ethics, Environment, Safety Executive Finance Management Development Nominating & Corporate
Committee & Health Committee Committee Committee & Compensation Committee Governance Committee

MARTIN MARIETTA 21